Search results for "ALZHEIMER'S DISEASE"

showing 10 items of 301 documents

18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification.

2019

Background and purpose While AD can be definitively confirmed by postmortem histopathologic examination, in vivo imaging may improve the clinician's ability to identify AD at the earliest stage. The aim of the study was to test the performance of amyloid PET using new processing imaging algorithm for more precise diagnosis of AD. Methods Amyloid PET results using a new processing imaging algorithm (MRI-Less and AAL Atlas) were correlated with clinical, cognitive status, CSF analysis, and other imaging. The regional SUVR using the white matter of cerebellum as reference region and scores from clinical and cognitive tests were used to create ROC curves. Leave-one-out cross-validation was carr…

Male18F-florbetabenAmyloidSensitivity and SpecificityAmyloid-PET Imaging030218 nuclear medicine & medical imagingWhite matter03 medical and health sciences0302 clinical medicineAlzheimer DiseasePositron Emission Tomography Computed Tomographymental disordersStilbenesmedicineImage Processing Computer-AssistedDementiaHumansRadiology Nuclear Medicine and imaging18F-florbetaben; Alzheimer's disease; Amyloid-PET Imaging; MR-lessAgedRetrospective StudiesPET-CTAniline CompoundsReceiver operating characteristicbusiness.industry18F-florbetaben Alzheimer's disease Amyloid-PET Imaging MR-less Aged Alzheimer Disease Female Humans Image Processing Computer-Assisted Magnetic Resonance Imaging Male Positron Emission Tomography Computed Tomography Retrospective Studies Sensitivity and Specificity Aniline Compounds StilbenesAlzheimer's diseasemedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureMR-lessFemaleNeurology (clinical)Differential diagnosisNuclear medicinebusiness030217 neurology & neurosurgeryPreclinical imagingFrontotemporal dementiaJournal of neuroimaging : official journal of the American Society of Neuroimaging
researchProduct

Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease.

2008

Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Western society mainly accounts for clinical dementia. Inflammation plays a key role in AD and dissecting the genetics of inflammation may provide an answer to the possible treatment. Hence, the better understanding of different molecular and cellular inflammatory mechanisms is crucial for complete knowledge of AD pathophysiology, and for its prevention and drug therapy. Accordingly, in the present study we evaluated whether the pro-inflammatory polymorphisms of lipopolysaccaride-receptors, +896A/G Toll-Like Receptor (TLR4) and -260C/T CD14, are risk factors for AD. The study included both 626 AD …

MaleALZHEIMER'S DISEASEINFLAMMATIONINNATE IMMUNITYTLR4CD14Lipopolysaccharide ReceptorsInflammationSingle-nucleotide polymorphismDiseaseSystemic inflammationPolymorphism Single NucleotideSeverity of Illness IndexDegenerative diseaseINFLAMMATIONAlzheimer DiseaseRisk FactorsDrug DiscoverymedicineDementiaSNPHumansTLR4AgedPharmacologyAged 80 and overbusiness.industryMiddle Agedmedicine.diseaseToll-Like Receptor 4ItalyALZHEIMER'S DISEASEImmunologyINNATE IMMUNITYFemalemedicine.symptomAlzheimer's diseasebusinessCD14
researchProduct

Association Between the HLA-A2 Allele and Alzheimer Disease

2006

In the elderly, the most common cause of dementia is Alzheimer disease (AD), which is responsible for the age-related progressive neurodegenerative inflammatory condition mediated by the disease. It has been seen that several genetic and environmental factors are involved in AD onset. Epidemiologic data suggest that some genetic determinants of AD might reside in those polymorphisms that regulate immune inflammatory responses, such as the major histocompatibility complex (MHC). Therefore, several MHC polymorphisms have been in the spotlight of a large number of AD association studies. A possible association of HLA-A2 allele with increased susceptibility to AD has been the subject of debate …

MaleAgingGenotypePopulationDiseaseBiologyGene FrequencyAlzheimer DiseaseHLA-A2 AntigenGenotypemedicineHumansGenetic Predisposition to DiseaseAlleleeducationAllele frequencyAgedGenetic associationAged 80 and overGeneticseducation.field_of_studyGenetic heterogeneityMiddle Agedmedicine.diseaseImmunologyFemaleGeriatrics and GerontologyAlzheimer's diseaseRejuvenation Research
researchProduct

Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.

2005

Abstract Different processes like microvascular dysfunction, free radical toxicity, β-amyloid deposits, and Wallerian degeneration can cause functionally relevant disturbances of cerebral neuronal networks by myelin degeneration. Color-coded diffusion-tensor-imaging (ccDTI) allows the structural identification and quantification of myelinated fiber tracts. Particularly, posterior cingulate fiber tracts, which are regarded as important neuronal substrates of the network representing memory processing can be localized only imprecisely by conventional magnetic resonance imaging techniques. The posterior cingulate bundles were assessed by ccDTI in 17 patients with amnestic mild cognitive impair…

MaleAgingWallerian degenerationPathologymedicine.medical_specialtyNeuropsychological TestsGyrus CinguliHippocampusNerve Fibers MyelinatedWhite matterAlzheimer DiseasePredictive Value of Testsmental disordersFractional anisotropyNeural PathwaysmedicineImage Processing Computer-AssistedDementiaHumansAgedMemory Disordersmedicine.diagnostic_testGeneral NeuroscienceMagnetic resonance imagingMiddle Agedmedicine.diseasemedicine.anatomical_structureDiffusion Magnetic Resonance Imagingnervous systemPosterior cingulateAnisotropyFemaleNeurology (clinical)Geriatrics and GerontologyAlzheimer's diseasePsychologyCognition DisordersNeuroscienceDevelopmental BiologyDiffusion MRINeurobiology of aging
researchProduct

Estimation of Short Temporal Intervals in Alzheimer's Disease

2000

This study investigated the estimation of short temporal intervals in Alzheimer's disease (AD). Eight patients with dementia of the Alzheimer type, and eight age-matched controls were evaluated in a time-estimation task. The task consisted in the production of three short empty intervals (5, 10, and 25 s). Results indicated that AD patients show deficits both in the accuracy and precision of time judgments: in the three intervals evaluated, the magnitude of absolute error and the variability in time judgments were significantly greater in AD patients than healthy respondents (p < .01). These findings are discussed taking into account the contribution of attentional processes during the perf…

MaleAgingmedicine.medical_specialtyAudiologyDevelopmental psychologyCentral nervous system diseaseArts and Humanities (miscellaneous)Alzheimer DiseaseReference ValuesmedicineHumansDementiaProspective StudiesCognitive declineProspective cohort studyGeneral PsychologyAgedEstimationCognitive disorderMiddle AgedTime perceptionmedicine.diseaseTime PerceptionFemaleGeriatrics and GerontologyAlzheimer's diseaseCognition DisordersPsychologyExperimental Aging Research
researchProduct

Comparison of motor strategies in sit-to-stand and back-to-sit motions between healthy and Alzheimer’s disease elderly subjects

2005

We studied the kinematics of shoulder displacement during sit-to-stand and back-to-sit in 6 healthy elderly subjects and six elderly subjects with mild to moderate Alzheimer's disease in order to elucidate the impact of Alzheimer's disease on motor planning and control processes. During sit-to-stand, Alzheimer's disease subjects reduced their forward displacement and started their upward displacement earlier than healthy elderly subjects. Furthermore, shoulder path curvatures were more pronounced for upward compared with downward displacement in healthy elderly group, in contrast with Alzheimer's disease group. Temporal analysis found that: 1) for both groups, profiles of velocity of sit-to…

MaleAgingmedicine.medical_specialtyTime FactorsMovementAccelerationPostureDiseaseEfferent PathwaysCentral nervous system diseaseDegenerative diseasePhysical medicine and rehabilitationAlzheimer DiseaseReference ValuesUpward displacementmedicinePostural BalanceHumansPostural BalanceAgedAged 80 and overLegMovement DisordersSit to standGeneral NeuroscienceBrainsocial sciencesmedicine.diseaseSurgeryArmFemaleAnalysis of varianceAlzheimer's diseasePsychologyPsychomotor PerformanceNeuroscience
researchProduct

Tumor Diagnosis Preceding Alzheimer's Disease Onset: Is There a Link Between Cancer and Alzheimer's Disease?

2012

Studies reporting an inverse association between Alzheimer's disease (AD) and cancer are scant. Available data are mostly based on ancillary findings of mortality data or obtained from studies evaluating frequency of neoplasms in AD patients independently if they occurred before or after AD. Moreover, some studies estimated frequencies of neoplasms in demented individuals, who were not necessarily AD patients. We estimated frequency of tumors preceding the onset of AD in AD patients and compared it to that of age- and gender-matched AD-free individuals. Occurrence of tumors preceding AD onset was assessed through a semi-structured questionnaire. Tumors were categorized as benign, malignant,…

MaleAlzheimer's disease cancer epidemiologyOncologymedicine.medical_specialtyDiseaseAssociationSex FactorsAlzheimer DiseaseRisk FactorsInternal medicineEpidemiologyOdds RatiomedicineHumansAge of OnsetAgedRetrospective StudiesAged 80 and overBrain Neoplasmsbusiness.industryGeneral NeuroscienceCase-control studyCancerRetrospective cohort studyGeneral MedicineOdds ratiomedicine.diseasePsychiatry and Mental healthClinical PsychologyCase-Control StudiesDisease ProgressionFemaleSettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseAge of onsetbusinessJournal of Alzheimer's Disease
researchProduct

Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetize…

2010

Diffusible oligomeric assemblies of the amyloid beta-protein (Abeta) could be the primary factor in the pathogenic pathway leading to Alzheimer's disease (AD). Converging lines of evidence support the notion that AD begins with subtle alterations in synaptic efficacy, prior to the occurrence of extensive neuronal degeneration. Recently, however, a shared or overlapping pathogenesis for AD and epileptic seizures occurred as aberrant neuronal hyperexcitability, as well as nonconvulsive seizure activity were found in several different APP transgenic mouse lines. This generated a renewed attention to the well-known comorbidity of AD and epilepsy and interest in how Abeta oligomers influence neu…

MaleAmyloidAmyloid betaHippocampusHippocampal formationMicroscopy Atomic ForceSettore BIO/09 - FisiologiaHippocampusRats Sprague-DawleyAtomic force microscopyAlzheimer's disease; Amyloid; Excitability; Oligomer; Atomic force microscopymental disordersAnimalsMolecular BiologyNeuronsAnalysis of VarianceExcitabilityAmyloid beta-PeptidesbiologyPerforant PathwayChemistryGeneral NeuroscienceDentate gyrusLong-term potentiationPopulation spikeAlzheimer's diseaseElectric StimulationPeptide FragmentsRatsElectrophysiologyElectrophysiologyOligomerbiology.proteinNeurology (clinical)NeuroscienceDevelopmental BiologyBrain research
researchProduct

Oxidative stress in patients with Alzheimer's disease: Effect of extracts of fermented papaya powder

2015

Brain tissue is particularly susceptible to oxidative stress (OS). Increased production of reactive oxygen species (ROS), reduced antioxidant systems, and decreased efficiency in repairing mechanisms have been linked to Alzheimer’s disease (AD). Postmortem studies in AD patients’ brains have shown oxidative damage markers (i.e., lipid peroxidation, protein oxidative damage, and glycoxidation). Fermented papaya (FPP, a product ofCarica papaya Linnfermentation with yeast) is a nutraceutical supplement with favorable effects on immunological, hematological, inflammatory, and OS parameters in chronic/degenerative diseases. We studied 40 patients (age 78.2 ± 1.1 years), 28 AD patients, and 12 co…

MaleAntioxidantSettore MED/09 - Medicina Internamedicine.medical_treatmentReview Articlemedicine.disease_causeAntioxidantsLipid peroxidationchemistry.chemical_compoundchemistry.chemical_classificationAged 80 and overbiologyCaricaBrainBiochemistry8-Hydroxy-2'-DeoxyguanosineFemalePowdersCaricaAlzheimer's diseaseAntioxidantCase-Control StudieReactive Oxygen SpecieOxidation-Reductionlcsh:RB1-214Humanmedicine.medical_specialtyUrinary systemImmunologyPowderAlzheimer DiseaseInternal medicinemedicinelcsh:PathologyHumansAgedDietary SupplementReactive oxygen speciesCase-control studyDeoxyguanosineOxidative StrePlant PreparationCell Biologybiology.organism_classificationmedicine.diseaseAged; Aged 80 and over; Alzheimer Disease; Antioxidants; Brain; Carica; Case-Control Studies; Deoxyguanosine; Dietary Supplements; Female; Fermentation; Humans; Lipid Peroxidation; Male; Oxidation-Reduction; Oxygen; Plant Preparations; Powders; Reactive Oxygen Species; Oxidative Stress; Immunology; Cell BiologyOxygenOxidative StressEndocrinologychemistryCase-Control StudiesDietary SupplementsFermentationPlant PreparationsLipid PeroxidationReactive Oxygen SpeciesOxidative stress
researchProduct

Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation

2007

BACKGROUND: A number of studies associate Alzheimer's disease with APOE polymorphism and alleles which favor the increased expression of immunological mediators such as cytokines or acute phase proteins. We integrated this information to better define risk and determine the relative importance of APOE and immunological mediators. METHODS: We investigated functional gene variants for APOE, IL-10 (3 loci), ACT (2 loci), HMGCR, IL-1alpha, IL-1beta, TNF-alpha, IFN-gamma, and IL-6 found for 260 AD patients and 190 controls enrolled in Northern Italy. A fuzzy latent classification approach, namely grade-of-membership analysis (GoM), was taken to identify extreme pure type risk sets, or profiles. …

MaleApolipoprotein EAgingGenotypeDiseaseBiologyApolipoproteins EAlzheimer DiseaseRisk FactorsGenotypeHumansGenetic Predisposition to DiseaseCognitive declineAlleleGeneAgedAged 80 and overGeneticsPolymorphism GeneticGeneral NeuroscienceAge FactorsAcute-phase proteinGenetic VariationAPOE IL-10 ACT HMGCR IL-1alpha IL-1beta TNF-alpha IFN-gamma IL-6 SNPs Grade of memebership Genetic risk profile Alzheimer's diseaseMiddle AgedUp-RegulationFemaleNeurology (clinical)Gene polymorphismInflammation MediatorsGeriatrics and GerontologyDevelopmental Biology
researchProduct